Melvin Spigelman
Direktor/Vorstandsmitglied bei AN2 THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Melvin Spigelman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AN2 THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.02.2022 | - |
Independent Dir/Board Member | 01.02.2022 | - | |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Direktor/Vorstandsmitglied | 01.06.2003 | - |
Vorstandsvorsitzender | 01.01.2009 | - | |
Präsident | 01.01.2009 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 01.06.2003 | 01.01.2009 | |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Private Equity Investor | 01.01.2005 | - |
Tres Cantos Open Lab Foundation
Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Melvin Spigelman
Ehemalige bekannte Positionen von Melvin Spigelman
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SYNERGY PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 21.08.2008 | 31.10.2018 |
Vorsitzender | 31.10.2018 | 01.05.2019 | |
Independent Dir/Board Member | 21.08.2008 | 31.10.2018 | |
THE MEDICINES COMPANY | Direktor/Vorstandsmitglied | 27.09.2005 | 01.01.2018 |
Independent Dir/Board Member | 27.09.2005 | 01.01.2018 | |
Hudson-Douglas Ltd. | Präsident | - | 01.06.2003 |
ABBOTT INDIA LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1992 | 01.01.2000 |
Corporate Officer/Principal | 01.01.2000 | 01.01.2001 | |
Knoll Pharmaceutical Co. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1992 | 01.01.2000 |
Corporate Officer/Principal | 01.01.2000 | 01.01.2001 | |
░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░ ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Melvin Spigelman
Brown University | Undergraduate Degree |
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Indien | 2 |
Deutschland | 2 |
Operativ
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ABBOTT INDIA LIMITED | Health Technology |
AN2 THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
Wellington Partners GmbH
Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto. | Finance |
Knoll Pharmaceutical Co. | |
Hudson-Douglas Ltd. | |
Tres Cantos Open Lab Foundation
Tres Cantos Open Lab Foundation Miscellaneous Commercial ServicesCommercial Services Tres Cantos Open Lab Foundation provides research facilities for charity. The non-profit company is based in Guildford, UK. | Commercial Services |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Melvin Spigelman
- Erfahrung